Yarrow Bioscience, Inc. (YARW)

NASDAQ: YARW · Real-Time Price · USD

41.52

+0.12 (0.29%)

At close: Aug 18, 2026, 4:00 PM EDT

32.72

-8.80 (-21.20%)

After-hours: Aug 18, 2026, 4:47 PM EDT

Yarrow Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Selling, General & Admin	1.56
Research & Development	2.42
Operating Expenses	3.98
Operating Income	-3.98
EBT Excluding Unusual Items	-3.98
Pretax Income	-283.98
Net Income	-283.98
Net Income to Common	-283.98
Net Income Growth	-
Shares Outstanding (Basic)	4
Shares Outstanding (Diluted)	4
Shares Change	-
EPS (Basic)	-66.82
EPS (Diluted)	-66.82
EPS Growth	-
EBIT	-3.98

SEC Filings: 10-K · 10-Q